Sang Yoon Kim

Latest publications

Hub genes in a pan-cancer co-expression network show potential for predicting drug responses.

  • Bioinformatics and Modelling
  • NORLUX-Glioma Biology
  • Discovery Proteomics
December 07, 2018
2018 Dec. F1000Res.7:1906. Accepted.
By:
  • Azuaje F
  • Kaoma T
  • Jeanty C
  • Nazarov P
  • Muller A
  • Kim S
  • Dittmar G
  • Golebiewska A
  • Niclou S.

Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.

  • Discovery Proteomics
  • Competence Center for Methodology and Statistics
  • Bioinformatics and Modelling
  • Clinical and Epidemiological Investigation Center
August 06, 2018
2018 Aug. Br J Cancer.119(5):580-590. Epub 2018 Aug 6.
By:
  • El-Khoury V
  • Beland M
  • Schritz A
  • Kim SY
  • Nazarov PV
  • Gaboury L
  • Sertamo K
  • Bernardin F
  • Batutu R
  • Antunes L
  • Bennett CW
  • Fays F
  • Berchem G
  • Kim YJ.

Large-scale targeted proteomics using internal standard triggered-parallel reaction monitoring (IS-PRM).

  • Discovery Proteomics
June 01, 2015
2015 Jun. Mol Cell Proteomics.14(6):1630-44. Epub 2015 Mar 9.
By:
  • Gallien S
  • Kim SY
  • Domon B.

Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.

  • Clinical Proteomics
  • Discovery Proteomics
March 06, 2015
2015 Mar. J Proteome Res.14(3):1412-9. Epub 2015 Feb 9.
By:
  • Kim YJ
  • Sertamo K
  • Pierrard MA
  • Mesmin C
  • Kim SY
  • Schlesser M
  • Berchem G
  • Domon B.

Technical considerations for large-scale parallel reaction monitoring analysis.

  • Discovery Proteomics
April 04, 2014
2014 Apr. J Proteomics.100:147-59. Epub 2013 Nov 4.
By:
  • Gallien S
  • Bourmaud A
  • Kim SY
  • Domon B.